Home > Who should come first in the queue for hepatitis C treatment?

[Drug and Alcohol Findings] (2016) Who should come first in the queue for hepatitis C treatment? Drug and Alcohol Findings Bulletin (22 March 2016)

URL: http://findings.org.uk/PHP/dl.php?file=De_Vos_AS_3...

In the UK context, this study’s findings imply that to prevent new cases it is best to focus expensive new treatments for hepatitis C infection on injectors who infrequently share their injecting equipment – patients most likely to be found and recruited via needle exchanges and addiction treatment services.

Key points from summary and commentary
• A simulation model based on what is known about the relevant factors assessed the expected impact on new infections of targeting treatment for hepatitis C infection at injectors at different degrees of risk of spreading the disease.
• Under core assumptions, where fewer than a third of injectors are already infected or fewer than half syringes contaminated, new infections are best averted by treating injectors who frequently risk infection by sharing injecting equipment; when the virus is more widespread, low-risk injectors are the best target.
• These conclusions are dependent on assumptions which may not be realistic or valid in the UK context.

Item Type:Evidence resource
Publication Type:Review
Drug Type:Opioid
Intervention Type:AOD disorder harm reduction
Source:Drug and Alcohol Findings
Date:March 2016
Number:22 March 2016
Subjects:G Health and disease > Disorder by cause > Communicable disease > Hepatitis C
J Health care, prevention and rehabilitation > Substance use prevention > Substance use harm reduction
J Health care, prevention and rehabilitation > Health related prevention > Health information and education > Communicable disease control
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Europe > United Kingdom

Repository Staff Only: item control page